vs
Amarin Corp plc（AMRN）与LandBridge Co LLC（LB）财务数据对比。点击上方公司名可切换其他公司
LandBridge Co LLC的季度营收约是Amarin Corp plc的1.1倍（$51.0M vs $45.1M），LandBridge Co LLC净利率更高（35.0% vs -23.3%，领先58.3%），LandBridge Co LLC同比增速更快（16.0% vs 7.0%），过去两年LandBridge Co LLC的营收复合增速更高（40.2% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
AMRN vs LB — 直观对比
营收规模更大
LB
是对方的1.1倍
$45.1M
营收增速更快
LB
高出9.0%
7.0%
净利率更高
LB
高出58.3%
-23.3%
两年增速更快
LB
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $51.0M |
| 净利润 | $-10.5M | $17.9M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 57.2% |
| 净利率 | -23.3% | 35.0% |
| 营收同比 | 7.0% | 16.0% |
| 净利润同比 | 33.0% | 15.6% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNLB
| Q1 26 | $45.1M | $51.0M | ||
| Q4 25 | $49.2M | $56.8M | ||
| Q3 25 | $49.7M | $50.8M | ||
| Q2 25 | $72.7M | $47.5M | ||
| Q1 25 | $42.0M | $44.0M | ||
| Q4 24 | $62.3M | $36.5M | ||
| Q3 24 | $42.3M | $28.5M | ||
| Q2 24 | $67.5M | $26.0M |
净利润AMRNLB
| Q1 26 | $-10.5M | $17.9M | ||
| Q4 25 | $-1.2M | $8.1M | ||
| Q3 25 | $-7.7M | $8.1M | ||
| Q2 25 | $-14.1M | $7.5M | ||
| Q1 25 | $-15.7M | $6.5M | ||
| Q4 24 | $-48.6M | $49.3M | ||
| Q3 24 | $-25.1M | $2.7M | ||
| Q2 24 | $1.5M | $-57.7M |
毛利率AMRNLB
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNLB
| Q1 26 | 35.5% | 57.2% | ||
| Q4 25 | -12.9% | 60.0% | ||
| Q3 25 | -22.4% | 60.8% | ||
| Q2 25 | -22.0% | 60.0% | ||
| Q1 25 | -39.9% | 57.0% | ||
| Q4 24 | -84.3% | 49.4% | ||
| Q3 24 | -59.5% | 11.2% | ||
| Q2 24 | -0.8% | -197.4% |
净利率AMRNLB
| Q1 26 | -23.3% | 35.0% | ||
| Q4 25 | -2.5% | 14.2% | ||
| Q3 25 | -15.6% | 15.9% | ||
| Q2 25 | -19.4% | 15.8% | ||
| Q1 25 | -37.4% | 14.7% | ||
| Q4 24 | -78.0% | 135.2% | ||
| Q3 24 | -59.4% | 9.3% | ||
| Q2 24 | 2.3% | -222.1% |
每股收益（稀释后）AMRNLB
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.24 | ||
| Q3 25 | $-0.02 | $0.26 | ||
| Q2 25 | $-0.03 | $0.24 | ||
| Q1 25 | $-0.04 | $0.20 | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.06 | $-0.04 | ||
| Q2 24 | $0.00 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $29.7M |
| 总债务越低越好 | — | $433.0K |
| 股东权益账面价值 | — | — |
| 总资产 | $645.8M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNLB
| Q1 26 | $307.8M | $29.7M | ||
| Q4 25 | $302.6M | $30.7M | ||
| Q3 25 | $286.6M | $28.3M | ||
| Q2 25 | $298.7M | $20.3M | ||
| Q1 25 | $281.8M | $14.9M | ||
| Q4 24 | $294.2M | $37.0M | ||
| Q3 24 | $305.7M | $14.4M | ||
| Q2 24 | $306.7M | $24.6M |
总债务AMRNLB
| Q1 26 | — | $433.0K | ||
| Q4 25 | — | $570.7M | ||
| Q3 25 | — | $366.1M | ||
| Q2 25 | — | $370.9M | ||
| Q1 25 | — | $375.5M | ||
| Q4 24 | — | $385.5M | ||
| Q3 24 | — | $242.4M | ||
| Q2 24 | — | $360.8M |
股东权益AMRNLB
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $340.3M | ||
| Q3 25 | $458.9M | $272.0M | ||
| Q2 25 | $464.9M | $266.4M | ||
| Q1 25 | $473.7M | $217.0M | ||
| Q4 24 | $486.2M | $211.8M | ||
| Q3 24 | $531.4M | $97.2M | ||
| Q2 24 | $551.9M | $296.4M |
总资产AMRNLB
| Q1 26 | $645.8M | $1.4B | ||
| Q4 25 | $670.8M | $1.4B | ||
| Q3 25 | $659.8M | $1.1B | ||
| Q2 25 | $670.1M | $1.1B | ||
| Q1 25 | $655.7M | $1.0B | ||
| Q4 24 | $685.3M | $1.0B | ||
| Q3 24 | $750.6M | $689.9M | ||
| Q2 24 | $799.9M | $710.5M |
负债/权益比AMRNLB
| Q1 26 | — | — | ||
| Q4 25 | — | 1.68× | ||
| Q3 25 | — | 1.35× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.73× | ||
| Q4 24 | — | 1.82× | ||
| Q3 24 | — | 2.49× | ||
| Q2 24 | — | 1.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $41.1M |
| 自由现金流经营现金流 - 资本支出 | — | $40.9M |
| 自由现金流率自由现金流/营收 | — | 80.3% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 2.30× |
| 过去12个月自由现金流最近4个季度 | — | $232.8M |
8季度趋势，按日历期对齐
经营现金流AMRNLB
| Q1 26 | — | $41.1M | ||
| Q4 25 | $15.3M | $126.3M | ||
| Q3 25 | $-12.7M | $34.9M | ||
| Q2 25 | $16.6M | $37.3M | ||
| Q1 25 | $-12.5M | $15.9M | ||
| Q4 24 | $-13.3M | $67.6M | ||
| Q3 24 | $-2.4M | $7.5M | ||
| Q2 24 | $-2.7M | $16.0M |
自由现金流AMRNLB
| Q1 26 | — | $40.9M | ||
| Q4 25 | — | $122.0M | ||
| Q3 25 | — | $33.7M | ||
| Q2 25 | — | $36.1M | ||
| Q1 25 | — | $15.8M | ||
| Q4 24 | — | $66.7M | ||
| Q3 24 | — | $7.1M | ||
| Q2 24 | — | $15.7M |
自由现金流率AMRNLB
| Q1 26 | — | 80.3% | ||
| Q4 25 | — | 214.9% | ||
| Q3 25 | — | 66.3% | ||
| Q2 25 | — | 75.9% | ||
| Q1 25 | — | 36.0% | ||
| Q4 24 | — | 182.6% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 60.4% |
资本支出强度AMRNLB
| Q1 26 | — | — | ||
| Q4 25 | — | 7.5% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 1.4% |
现金转化率AMRNLB
| Q1 26 | — | 2.30× | ||
| Q4 25 | — | 15.68× | ||
| Q3 25 | — | 4.31× | ||
| Q2 25 | — | 4.98× | ||
| Q1 25 | — | 2.46× | ||
| Q4 24 | — | 1.37× | ||
| Q3 24 | — | 2.80× | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
LB
| Other | $14.2M | 28% |
| Easements and other surface-related revenues | $11.6M | 23% |
| Surface use royalties - related party | $11.0M | 22% |
| Resource sales | $5.2M | 10% |
| Resource royalties | $4.3M | 8% |
| Easements and other surface-related revenues - related party | $3.2M | 6% |
| Resource royalties - related party | $1.3M | 2% |
| Resource sales - related party | $205.0K | 0% |
